The Value of Cytochrome P450 2C19 Pharmacogenomic Information for Patients Receiving Clopidogrel Therapy Following a Major Cardiovascular Event: Evidence from Geisinger

Rebecca A. Pulk, Jove Graham, Frank Lichtenberg, Daniel Maeng, Marc S. Williams and Eric Wright

A chapter in Economic Dimensions of Personalized and Precision Medicine, 2018, pp 273-304 from National Bureau of Economic Research, Inc

Date: 2018
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.nber.org/chapters/c13993.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nbr:nberch:13993

Ordering information: This item can be ordered from
http://www.nber.org/chapters/c13993

Access Statistics for this chapter

More chapters in NBER Chapters from National Bureau of Economic Research, Inc National Bureau of Economic Research, 1050 Massachusetts Avenue Cambridge, MA 02138, U.S.A.. Contact information at EDIRC.
Bibliographic data for series maintained by ().